Sign in
8-K

Current Report

Coherus Oncology, Inc. Filed Acc 0001193125-17-214840

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading d405712d8k.htm…